Skip to main contentSkip to footer
A finger pointing at a scan
Brighton & Sussex Medical School

Staff Profiles

BSMS > About BSMS > Contact us > Staff > Lucy Matthews

Lucy Matthews

Miss Lucy Matthews (BSc Hons)

Clinical Trials Coordinator
T: +44 (0)1273 877919
Location: Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Room 6, University of Sussex, Brighton, BN1 9PX

Areas of expertise:Patient reported outcomes; quality of life; clinical trials
Research areas: Clinical trials; breast surgical trials


Lucy Matthews completed her degree in Biochemistry with Neurobiology (2000) at the University of Sussex. She worked in forensic science and as a research scientist specialising in prostate cancer, before joining SHORE-C. At SHORE-C Lucy is responsible for coordinating the quality of life studies for many of our research projects and clinical trials. She focuses on breast surgical trials and her research concentrates on recruitment to these potentially difficult to recruit to trials. 


EXperiences of TREatment and Quality Of Life of men with mCRPC (EXTREQOL)

Selected publications

EXTREQOL Identifies Ongoing Challenges in Maximising Quality of Survival in Men with Metastatic Castrate-Resistant Prostate Cancer Jenkins V, Payne H, Mason M, May S, Matthew L, Catt S. Clinical Oncology. June 2018 Volume 30, Issue 6, Pages 331–333

Do drugs offering only PFS maintain quality of life sufficiently from a patient’s perspective? Results from AVALPROFS (Assessing the ‘VALue’ to patients of PROgression Free Survival) study.  Jenkins V, Farewell V, May S, Catt S, Matthews L, Schilling V, Dickson J, Simcock R, Fallowfield L Supportive Care in Cancer. 15 May 2018

Enhancing decision-making about adjuvant chemotherapy in early breast cancer following EndoPredict testing.

Fallowfield L, Matthews L, May S, Bloomfield D Psycho-Oncology. April 2018 Volume 27, Issue 4, Pages: 1264-1269

Fallowfield L, Matthews L, Francis A, Jenkins V, Rea D. Low grade Ductal Carcinoma in situ (DCIS): How best to describe it?. The Breast, 23(5); 693-696

Francis A, Thomas J, Fallowfield L, Wallis M, Bartlett JMS, Brookes C, Roberts T, Pirrie S, Gaunt C, Young J, Billingham L, Dodwell D, Hanby A, Pinder SE, Evans A, Reed M, Jenkins V, Matthews L, Wilcox M, Fairbrother P, Bowden S, Rea D.  Addressing overtreatment of screen detected DCIS; the LORIS trial.  European Journal of Cancer, Article first published online 18th August 2015 ahead of print